Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NSMF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TYRO3P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ORC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MNT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSNARE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929488 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMAD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCYT1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTMR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERPINA7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GFM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXCL14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C3orf80 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPD1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMO4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on